Cancer News


Researcher contributes to debate on breast cancer gene screening

There has been much recent debate on the benefits and risks of screening for breast cancer using BRCA1 and BRCA2 mutations in the general adult population. With an estimated 235,000 new breast ...

Tue 25 Nov 14 from Medical Xpress

Other sources: Medical Xpress, ScienceDaily show all (3)

Team uses e-health records to search for hidden drug benefits

With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden ...

Tue 25 Nov 14 from Medical Xpress

Other sources: Medical Xpress, ScienceDaily show all (3)

Efficacy of new drug against stem cells that provoke cancer and its metastasis

An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, ...

Wed 26 Nov 14 from Medical Xpress

Other sources: Medical Xpress show all (2)

Adult survivors of childhood eye cancer experience few cognitive or social setbacks

Adult survivors of retinoblastoma, a type of eye cancer that usually develops in early childhood, have few cognitive or social problems decades following their diagnosis and treatment. That's ...

Mon 24 Nov 14 from Medical Xpress

Other sources: Medical Xpress, HealthCanal show all (3)

Study finds provider-focused intervention improves HPV vaccination rates

Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves Human Papilloma virus ...

Mon 24 Nov 14 from Medical Xpress

Other sources: Medical Xpress, ScienceDaily show all (3)

With gene mutations, second breast cancer risk rises over time

Women who are genetically susceptible to breast cancer and develop it in one breast are at higher than average risk for a tumor in the other breast, and that risk may increase as time goes on, ...

Fri 21 Nov 14 from FOXNews

Other sources: FOXNews, Reuters show all (3)

High-dose interleukin-2 effective in mRCC pre-treated with VEGF-targeted therapies

High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology ...

Mon 24 Nov 14 from Medical Xpress

Other sources: Medical Xpress, Eurekalert show all (3)

One-two punch of drugs better than either alone against colorectal cancer

Genes make proteins and proteins tell your body's cells what to do: one talks to the next, which talks to the next, and to the next. Like a game of telephone, researchers call these "signaling ...

Tue 25 Nov 14 from Medical Xpress

Other sources: Medical Xpress show all (2)

Why cancer cells grow despite a lack of oxygen

Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications ...

Tue 25 Nov 14 from Medical Xpress

Other sources: Medical Xpress show all (2)

The risk factor new evidence on obesity and prostate cancer

Casting an eye over our cancer prevention infographic it's noticeable that there's no mention of prostate cancer. That's because, until now, researchers haven't been able to uncover much about ...

Mon 24 Nov 14 from Medical Xpress

Other sources: Medical Xpress (2), Reuters show all (3)

Show more »